Literature DB >> 26677089

Cardiovascular risk factors and increased carotid intima-media thickness in young patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.

Tânia Maria Barreto Rodrigues1, Cristina Botelho Barra2, Jovita Lane Soares Santos3, Eugênio Marcos Andrade Goulart2, Adaliene Versiani Matos Ferreira4, Ivani Novato Silva2.   

Abstract

OBJECTIVE: Increased arterial intima-media thickness has been observed in adults with congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency (21-OHD). CAH has also been associated with obesity, insulin resistance, and hypertension. The aim of the present study was to compare youths with CAH with healthy, normal-weight individuals, evaluating carotid intima-media thickness (CIMT) and indicative factors of cardiovascular risk to seek for abnormalities in the CAH group. SUBJECTS AND METHODS: Clinical, biochemical, and ultrasonographic evaluations, according to published criteria, were performed in 113 subjects (5 to 20 years old): 40 patients with 21-OHD and 73 healthy individuals matched for gender, pubertal status, and age.
RESULTS: Most CAH patients were female (80%), salt-losers (72.5%), and pubescent (80%); 10 (25%) patients were overweight. An increase in CIMT was observed both on the right (p = 0.0240) and left (p = 0.0003) sides in 38 CAH patients compared with the healthy individuals. The body mass index, BMI/age Z score, and systolic blood pressure (SBP) were higher in patients compared with controls (p < 0.000 and p = 0.0219, respectively).
CONCLUSIONS: Findings of increased CIMT, BMI, and SBP in young patients with 21-OHD indicate the need for early identification and intervention regarding cardiovascular risk. Validating these findings might result in improved therapeutic approaches for children with 21-OHD in the future.

Entities:  

Mesh:

Year:  2015        PMID: 26677089     DOI: 10.1590/2359-3997000000119

Source DB:  PubMed          Journal:  Arch Endocrinol Metab        ISSN: 2359-3997            Impact factor:   2.309


  5 in total

1.  Assessment of cardiac function in children with congenital adrenal hyperplasia: a case control study in Cameroon.

Authors:  J Tony Nengom; S Sap Ngo Um; D Chelo; R Mbono Betoko; J Boombhi; F Mouafo Tambo; A Chiabi; S Kingue; P Koki Ndombo
Journal:  BMC Pediatr       Date:  2017-04-20       Impact factor: 2.125

Review 2.  Components of Metabolic Syndrome in Youth With Classical Congenital Adrenal Hyperplasia.

Authors:  Mimi S Kim; Nicole R Fraga; Nare Minaeian; Mitchell E Geffner
Journal:  Front Endocrinol (Lausanne)       Date:  2022-03-24       Impact factor: 5.555

Review 3.  Metabolic syndrome and cardiovascular morbidity in patients with congenital adrenal hyperplasia.

Authors:  Mattia Barbot; Pierluigi Mazzeo; Martina Lazzara; Filippo Ceccato; Carla Scaroni
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-01       Impact factor: 6.055

4.  Genotypic spectrum of 21-hydroxylase deficiency in an endogamous population.

Authors:  R A A Mahmoud; N H Amr; N N Toaima; T M Kamal; H H Elsedfy
Journal:  J Endocrinol Invest       Date:  2021-08-02       Impact factor: 4.256

5.  The relationship of carotid intima-media thickness with anthropometric and metabolic parameters in patients with classic congenital adrenal hyperplasia

Authors:  Hale Tuhan; Tülay Öztürk; Gönül Çatlı; Sezer Acar; Ayhan Abacı; Tuğba Egeli; Korcan Demir; Şule Can; Handan Güleryüz; Bumin Dündar; Ece Böber
Journal:  Turk J Med Sci       Date:  2021-08-30       Impact factor: 0.973

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.